Santen Pharmaceutical Co., Ltd.
9.50
EUR
0.00
(0.00%)
Important Dates
Santen Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 5, 2026.
| Earnings Date | 11/5/2026 |
Share Statistics
As of March 31, 2026, Santen Pharmaceutical Co., Ltd. has 321.68M shares outstanding.
| Shares Outstanding | 321.68M |
Financial Position
As of March 31, 2026, Santen Pharmaceutical Co., Ltd. maintains a current ratio of 2.60, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.60 |
| Quick Ratio | 0.95 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 3,878.75 |
Balance Sheet
EURThese figures are as of March 31, 2026. Total book value stands at 1.62B, with working capital of 768.09M providing operational flexibility.
| Cash & Cash Equivalents | 454.40M |
| Net Debt | -440.91M |
| Equity (Book Value) | 1.62B |
| Book Value Per Share | 5.03 |
| Working Capital | 768.09M |
Stock Splits
Santen Pharmaceutical Co., Ltd.'s most recent stock split took place on March 27, 2015 with a 1:5 split ratio.
| Last Split Date | 3/27/2015 |
| Split Ratio | 1:5 |